Frequency of Deleterious Germline Variants in HER2-Low Breast Cancer Patients Using a Hereditary Multipanel Gene Testing.
Cassoli JPB, Fernandes Í, Carvalho L, Fernandes M, Centrone AF, Taniwaki L, Lima RC, Junior UDR, Dias IWR, Taranto P, Beal J, de Lima FT, Moura F, Cendoroglo M, Araújo SEA, Uson Junior PLS.
Cassoli JPB, et al. Among authors: taniwaki l.
Curr Issues Mol Biol. 2024 Jul 25;46(8):7976-7985. doi: 10.3390/cimb46080471.
Curr Issues Mol Biol. 2024.
PMID: 39194688
Free PMC article.